Log In
Print this Print this

intramuscular DUR-928

  Manage Alerts
Collapse Summary General Information
Company Durect Corp.
DescriptionEndogenous small molecule epigenomic modulator of cellular activities
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard Indication Renal (unspecified)
Indication DetailsTreat acute kidney injury (AKI)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today